Patent · US Active

GAK modulators

US9518066B2 · kind B2 · utility

1Cited by

0References

12Claims

0Family size

Assignee

Katholieke Universiteit Leuven, KU LEUVEN R&D · BE

Inventors

Piet Herdewijn · Heverlee, BE
Steven De Jonghe · Brussels, BE
Sona Kovachova · Leuven, BE
Lei Chang · Heverlee, BE
Michal Sala · Kladno, CZ

Key dates

Filing date	Jul 4, 2014
Grant date	Dec 13, 2016
Priority date	—
Expiry date	Jul 4, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to a class of novel isothiazolo[4,3-b]pyridine derivatives and a method for their preparation, as well as to pharmaceutical compositions comprising one or more of said isothiazolo[4,3-b]pyridine derivatives and one or more pharmaceutically acceptable excipients. The present invention further relates to the use of said novel isothiazolo[4,3-b]pyridine derivatives as biologically active ingredients, more specifically as medicaments for the treatment of disorders and pathologic conditions such as, but not limited to, cell-proliferative and neurodegenerative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.